RE:Interview with Roger Dumoulin-White Eoganacht ... Excellent catch regarding this additional visibility (dated if August 26).
Looks like our usual grumbler whined too early once again and will say that it's not sufficient enough and that we're all yes men because we don't panic like him!
Of course, things are never evolving fast enough. But Welch reached key milestones that allowed us to enter the commercialization stage. So we're getting there and will get there, with a positive outcome. Processes (FDA Breakthrough application and jv discussions) have been announced, initiated and are on-going. TLT has done what it had to do. Some lack understanding of how complex and slow are those processes but we have no way to doubt that we will get there.
Just to sign a jv deal, Ferrings took 9 months, from the moment it was officially granted FDA commercialization, despite 2y of delays caused by manufacturing issues. TLT won't have such manufacturing issues because of the nature of our molecule. And we will strike a jv deal before full commercialization.
Ferring got 500M$ (200M$ + 300M$) in exchange of 5-8% royalties for the US market. It will be interesting to see how much higher we get. Makes me think that major pharmas left FERRING's ADSTILADRIN to an obscured (less known) pharma (Royalty Pharma). Hopefully because they see a much bigger potential with our treatment.
Merck clearly seems to be the partner of ImmunityBio because of ImmunityBio's N-803 has been trial with BCG and is also being trialed with Keytruda.